Eton Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.038; its P/E ratio is -83.55; Eton Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 7.03M	$ 12.00M	$ 5.30M	$ 8.50M	$ 3.22M
Gross Profit	$ 4.40M	$ 9.68M	$ 3.35M	$ 6.23M	$ 2.02M
EBIT	$ 226.00K	$ 4.56M	$ -4.54M	$ 1.06M	$ -2.90M
EBITDA	$ 457.00K	$ 4.80M	$ -4.30M	$ 1.34M	$ -2.73M
Net Income Common Stockholders	$ -579.00K	$ 4.56M	$ 13.02M	$ 912.00K	$ -3.04M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 22.07M	$ 21.57M	$ 14.71M	$ 16.30M	$ 13.38M
Total Assets	$ 31.53M	$ 30.93M	$ 23.87M	$ 25.03M	$ 21.52M
Total Debt	$ 5.78M	$ 6.16M	$ 6.53M	$ 6.52M	$ 6.39M
Net Debt	$ -16.29M	$ -15.41M	$ -8.18M	$ -9.78M	$ -6.99M
Total Liabilities	$ 14.63M	$ 14.21M	$ 12.69M	$ 11.95M	$ 10.34M
Stockholders Equity	$ 16.89M	$ 16.73M	$ 11.24M	$ 13.08M	$ 11.18M
Cash Flow	-
Free Cash Flow	$ 873.00K	$ 7.10M	$ -1.55M	$ 2.83M	$ -3.70M
Operating Cash Flow	$ 873.00K	$ 7.10M	$ -1.55M	$ 2.84M	$ -1.70M
Investing Cash Flow	-	-	-	$ -12.00K	$ -2.00M
Financing Cash Flow	$ -368.00K	$ -246.00K	$ -49.00K	$ 99.00K	$ 35.00K

Currency in USD

Eton Pharmaceuticals Earnings and Revenue History

Income Statement >

Eton Pharmaceuticals Debt to Assets

Balance Sheet >

Eton Pharmaceuticals Cash Flow

Cash Flow >

Eton Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing